We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Reference Ranges Established for Automated Cerebrospinal Fluid Cell Count

By LabMedica International staff writers
Posted on 11 Feb 2014
Cerebrospinal fluid (CSF) cell count is an important analysis in the investigation of central nervous system (CNS) infections, and new reference ranges for leukocytes in the CSF have been established. More...


The references ranges for granulocytes, lymphocytes, and monocytes in the CSF were originally based on manual counts, but since the introduction of automated cell counters, these ranges have not been revised, or abnormalities connected to diseases.

Infectious disease specialists at the Sahlgrenska Academy (Gothenburg, Sweden) analyzed CSF from 80 neurologically healthy volunteers. For the differential diagnosis section, they analyzed cell counts and hospital records from 175 patients with CSF mononuclear pleocytosis, which is an increased cell count particularly an increase in white blood cell (WBC) count, in a bodily fluid, such as CSF.

Manual CSF cell counting was performed and compared with automated CSF cell counting was performed on a ADVIA 2120i instrument within one hour of sampling using the ADVIA 2120i CSF Assay (Siemens, Erlangen, Germany). The method requires 300 μL of CSF and reports counts for erythrocytes, lymphocytes, monocytes and granulocytes, which are differentiated on the basis of size, absorbance and light scattering characteristics.

Correlation between manual and automated cell counts was excellent for erythrocytes, but was lower for leukocytes, when erythrocyte counts were lower than 250 cells/μL. For the neurologically healthy volunteers studied in the reference range section, the 95th percentile was 3.0 cells/μL for lymphocytes, 1.0 cell/μL for monocytes, and 1.0 cell/μL for granulocytes. In the differential diagnosis section, comparisons were done between the groups with Lyme neuroborreliosis and viral CNS infection. There were no significant differences between these two groups regarding cell counts; neither for lymphocytes, median 58 cells/μL vs. 72 cells/μL; nor for monocytes, median 13 cells/μL vs. 16 cells/μL; nor for granulocytes, median 1 cell/μL vs. 2 cells/μL.

The authors suggested that new reference ranges of less than 4 cells/μL for lymphocytes, less than 3 cells/μL for monocytes, and less than 3 cells/μL for granulocytes for CSF leukocytes when automatically analyzed with the Siemens ADVIA 2120i. The separation of mononuclear cells into lymphocytes and monocytes did not facilitate the discrimination between Lyme neuroborreliosis and viral CNS infection. The study was published in the January 2014 issue of the journal Clinical Biochemistry.

Related Links:

Sahlgrenska Academy
Siemens 



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.